Bombax Healthcare Acquisition registered to foffer 5 million units to be priced at $10 each. A unit consists of one Class A ordinary share and one-half of a warrant.
The SPAC expects to target a business in the healthcare industry or a healthcare-related sector.
Bombax is led by CEO and President Jeffrey Yam, an executive director at Integrated Capital Limited, a Hong Kong-based multi-strategy private investment firm.
Underwriter JonesTrading Institutional Services has an option to purchase up to an additional 750,000 units to cover over-allotments, if any.
Bombax said it has applied for a Nasdaq listing but has not yet selected a ticker symbol. Read more.
